Leick, M. B., Maus, M. V., & Frigault, M. J. (2021). Clinical Perspective: Treatment of Aggressive B Cell Lymphomas with FDA-Approved CAR-T Cell Therapies. Mol Ther.
Citación estilo ChicagoLeick, Mark B., Marcela V. Maus, y Matthew J. Frigault. "Clinical Perspective: Treatment of Aggressive B Cell Lymphomas With FDA-Approved CAR-T Cell Therapies." Mol Ther 2021.
Cita MLALeick, Mark B., Marcela V. Maus, y Matthew J. Frigault. "Clinical Perspective: Treatment of Aggressive B Cell Lymphomas With FDA-Approved CAR-T Cell Therapies." Mol Ther 2021.
Precaución: Estas citas no son 100% exactas.